CIK 0001580149 · Non-accelerated filer<br>Smaller reporting company
BIOVIE INC.
Sign in to watch- Ticker
- BIVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 462510769
- Phone
- 775-888-3162
- Business address
- 680 W NYE LANE, SUITE 201, CARSON CITY, NV, 89703
- Former names
- NANOANTIBIOTICS, INC.
Securities
- BIVI Common stock Nasdaq
- BIVIW Warrant Nasdaq
- CORRESP Other Correspondence Between Filers and SEC Staff
- 10-Q Report Quarterly Report
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 4 Open-market buy Director bought 2,430 shares at $7.95 ($19,319)
- 4 Open-market buy Director bought 2,570 shares at $7.97 ($20,483)
- 5 Insider Annual Insider Trading Report
- 10-Q Report Quarterly Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Open-market buy Director bought 5,000 shares at $9.19 ($45,950)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
Page 16 of 26 · 511 filings